
SKINPOWER Re-New Cream
SK-II Skinpower Re-New Airy Cream: Unveil the Power of Plump
Experience the transformative power of SK-II’s innovative skincare formula that uplifts your beauty, leaving you with irresistable appearance of plump, lifted skin look.Â
Infused with SK-II’s iconic Pitera™, the Skinpower Re-New Cream revitalizes your complexion. Enhanced by Coumaric Acid and Peony extract, this airy cream is hydrating to not only reduce fine lines but also boosts skin firmness*, ensuring your skin feels as vibrant as it looks.
*Based on consumer self assessment, Â product use study among 63 women, Feb 2025, Japan.Â
** Based on third party agency Ellead, clinical study among 32 females, in December 2024, Korea
SK-II Skinpower Re-New Airy Cream: Unveil the Power of Plump
Experience the transformative power of SK-II’s innovative skincare formula that uplifts your beauty, leaving you with irresistable appearance of plump, lifted skin look.Â
Infused with SK-II’s iconic Pitera™, the Skinpower Re-New Cream revitalizes your complexion. Enhanced by Coumaric Acid and Peony extract, this airy cream is hydrating to not only reduce fine lines but also boosts skin firmness*, ensuring your skin feels as vibrant as it looks.
*Based on consumer self assessment, Â product use study among 63 women, Feb 2025, Japan.Â
** Based on third party agency Ellead, clinical study among 32 females, in December 2024, Korea
Description
SK-II Skinpower Re-New Airy Cream: Unveil the Power of Plump
Experience the transformative power of SK-II’s innovative skincare formula that uplifts your beauty, leaving you with irresistable appearance of plump, lifted skin look.Â
Infused with SK-II’s iconic Pitera™, the Skinpower Re-New Cream revitalizes your complexion. Enhanced by Coumaric Acid and Peony extract, this airy cream is hydrating to not only reduce fine lines but also boosts skin firmness*, ensuring your skin feels as vibrant as it looks.
*Based on consumer self assessment, Â product use study among 63 women, Feb 2025, Japan.Â
** Based on third party agency Ellead, clinical study among 32 females, in December 2024, Korea























